home / stock / iqaif / iqaif short
Short Information | IQ-AI Limited (OTCMKTS:IQAIF)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 638,046 |
Total Actual Volume | 2,168,046 |
Short Trends | |
---|---|
Cover Days | 2 |
Short Days | 11 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 31,902 |
Average Short Percentage | 56.44% |
Is there a IQAIF Short Squeeze or Breakout about to happen?
See the IQAIF Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
02-14-2024 | $0.029 | $0.029 | $0.029 | $0.029 | 200,000 | 200,000 | 100% |
02-13-2024 | $0.031 | $0.031 | $0.031 | $0.031 | 100,000 | 100,000 | 100% |
01-16-2024 | $0 | $0.046 | $0 | $0 | 48 | 48 | 100% |
01-10-2024 | $0.05 | $0.046 | $0.05 | $0.046 | 1,055,000 | 235,000 | 22.27% |
01-09-2024 | $0.052 | $0.0517 | $0.055 | $0.05 | 760,000 | 50,000 | 6.58% |
10-23-2023 | $0.046 | $0.046 | $0.046 | $0.046 | 25,000 | 25,000 | 100% |
08-02-2023 | $0 | $0.021 | $0 | $0 | 202 | 202 | 100% |
07-31-2023 | $0 | $0.021 | $0 | $0 | 48 | 48 | 100% |
07-27-2023 | $0 | $0.021 | $0 | $0 | 20 | 20 | 100% |
07-26-2023 | $0 | $0.021 | $0 | $0 | 28 | 28 | 100% |
06-02-2022 | $0.054 | $0.062 | $0.062 | $0.054 | 25,000 | 25,000 | 100% |
06-01-2022 | $0.06 | $0.06 | $0.06 | $0.06 | 200 | 200 | 100% |
10-07-2021 | $0.0848 | $0.0848 | $0.0848 | $0.0848 | 2,500 | 2,500 | 100% |
News, Short Squeeze, Breakout and More Instantly...
(NewsDirect) Dr Jennifer Connelly, MD, the Principal Investigator (PI) of the IQ-AI Limited sponsored phase one clinical trial that is being conducted at the Medical College of Wisconsin, joined Proactive's Stephen Gunnion with a positive update from its treatment for recurring glioblasto...
--News Direct-- Dr Jennifer Connelly, the Principal Investigator (PI) of the IQ-AI Limited sponsored Phase I Clinical Trial that is being conducted at the Medical College of Wisconsin, joins Proactive's Natalie Stoberman to discuss the latest updates from its treatment for recurring gliob...
MILWAUKEE, WI / ACCESSWIRE / July 13, 2023 / Imaging Biometrics, LLC (IB) , a wholly-owned subsidiary of IQ-AI Ltd (LSE:IQAI)(OTCQB:IQAIF) , today announced the U.S. Food and Drug Administration (US FDA) has granted Orphan Drug Designation (ODD) for gallium maltolate (GaM) for the treatment of p...